These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16424974)

  • 1. Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae.
    Abele-Horn M; Stoy K; Frosch M; Reinert RR
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):55-7. PubMed ID: 16424974
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone-resistant Streptococcus pneumoniae.
    Pletz MW; Fugit RV; McGee L; Glasheen JJ; Keller DL; Welte T; Klugman KP
    Emerg Infect Dis; 2006 Sep; 12(9):1462-3. PubMed ID: 17073107
    [No Abstract]   [Full Text] [Related]  

  • 3. Streptococcus pneumoniae antimicrobial susceptibility testing.
    Venglarcik JS
    Pediatr Infect Dis J; 2000 Apr; 19(4):329-31. PubMed ID: 10783024
    [No Abstract]   [Full Text] [Related]  

  • 4. Optochin revisited: defining the optimal type of blood agar for presumptive identification of Streptococcus pneumoniae.
    Gardam MA; Miller MA
    J Clin Microbiol; 1998 Mar; 36(3):833-4. PubMed ID: 9508326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.
    Jorgensen JH; Crawford SA; McElmeel LM; Whitney CG
    J Clin Microbiol; 2004 Dec; 42(12):5928-30. PubMed ID: 15583344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.
    Millichap JJ; Pestova E; Siddiqui F; Noskin GA; Peterson LR
    J Clin Microbiol; 2001 Jul; 39(7):2719-21. PubMed ID: 11427605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the BD phoenix automated microbiology system SMIC/ID-2 panel for antimicrobial susceptibility testing of Streptococcus pneumoniae].
    Lee KK; Ryoo NH; Kim ST; Chae SL; Huh HJ
    Korean J Lab Med; 2009 Jun; 29(3):212-7. PubMed ID: 19571618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014.
    Kim SH; Bae IK; Park D; Lee K; Kim NY; Song SA; Kim HR; Jeon GW; Urm SH; Shin JH
    Biomed Res Int; 2016; 2016():6950482. PubMed ID: 27314035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.
    Wortmann GW; Bennett SP
    Clin Infect Dis; 1999 Dec; 29(6):1599-600. PubMed ID: 10585837
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility testing of Streptococcus pneumoniae and Viridans streptococcal isolates against: quinolones, oxazolidinones and glycopeptides.
    Băncescu G; Neagu AS; Radu-Popescu M; Nica M; Dascălu A; Nistor I; Bărbuceanu SF; Băncescu A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):286-90. PubMed ID: 23077910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ciprofloxacin susceptibility tests relevant for Streptococcus pneumoniae?
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1996 Jul; 38(1):151-3. PubMed ID: 8858469
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China.
    Pan F; Han L; Huang W; Tang J; Xiao S; Wang C; Qin H; Zhang H
    PLoS One; 2015; 10(11):e0142892. PubMed ID: 26571373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New BSAC sensitivity testing guidelines.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1999 Dec; 44(6):850-1. PubMed ID: 10590292
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Pawlak J; Belian B
    Clin Microbiol Infect; 2001 Oct; 7(10):572-3. PubMed ID: 11683802
    [No Abstract]   [Full Text] [Related]  

  • 16. Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin.
    Fuchs PC; Barry AL; Brown SD
    J Chemother; 1997 Dec; 9(6):391-3. PubMed ID: 9491837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
    Choi SH; Park SJ; Jun JB; Lee SR; Jeon MH; Kwon HH; Kim SC; Kim MN; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2007 May; 58(1):141-3. PubMed ID: 17368803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients].
    Firat M; Ersoy Y; Eşel D; Bayraktar M; Caylan R; Durmaz R
    Mikrobiyol Bul; 2006 Jul; 40(3):169-77. PubMed ID: 17001845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Rapid System for Antimicrobial Identification and Antimicrobial Susceptibility Testing in Pediatric Bloodstream Infections.
    Ward E; Weller K; Gomez J; Roman K; Cárdenas AM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925640
    [No Abstract]   [Full Text] [Related]  

  • 20. Variability of β-lactam susceptibility testing for Streptococcus pneumoniae using 4 commercial test methods and broth microdilution.
    Charles MK; Berenger BM; Turnbull L; Rennie R; Fuller J
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):240-5. PubMed ID: 26707068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.